GlaxoSmithKline on its remote desktop interface for independent reanalysis of drug trial dataBMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g4898 (Published 30 July 2014) Cite this as: BMJ 2014;349:g4898
- James Shannon, chief medical officer1
- 1GlaxoSmithKline, Brentford TW8 9GS, UK
We launched our system in May 2013 to provide researchers with access to patient level data from our studies in the belief that greater access to these data would facilitate further research to advance medical science and lead to improvements in patient care. I am sorry that Jureidini and his team have had difficulty working within the system.1 We worked hard to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial